Environmental factors and risk for hepatocellular carcinoma
- PMID: 15508106
- DOI: 10.1016/j.gastro.2004.09.018
Environmental factors and risk for hepatocellular carcinoma
Abstract
Chronic infections with hepatitis B virus (HBV) and hepatitis C virus (HCV) are the most important risk factors for the development of hepatocellular carcinoma (HCC) in humans. HBV is the primary cause of HCC in high-risk areas including China and Africa, whereas in developed countries such as the United States, HCV plays a more prominent role and is at least partially responsible for the increase in HCC incidence in this country. Humans are exposed to hepatocarcinogenic aflatoxins through ingestion of moldy foods, a consequence of poor storage of susceptible grains. Highly exposed populations are primarily in sub-Sahara Africa and Asia, where dietary aflatoxins significantly enhance the carcinogenic effects of viral hepatitis. Heavy, long-term alcohol use is a risk factor for HCC, whereas moderate use (1-3 drinks/day) is not. Constituents of cigarette smoke are hepatic carcinogens in animals, and there is mounting evidence that the liver is an organ susceptible to tobacco carcinogenicity. Diabetic patients are at risk for HCC probably as a result of the hepatic injury, fibrosis, and eventual cirrhosis resulting from fatty liver disease. Given the current epidemic of obesity and diabetes in the United States, this risk factor will be increasingly important. Increased risk for HCC is evident in young noncirrhotic users of oral contraceptives in the United States and Europe. In summary, risk factors for HCC are identifiable in most patients and primarily are associated with chronic hepatic injury.
Similar articles
-
[Role of environmental factors in the etiology of hepatocellular carcinoma].Orv Hetil. 2010 Jul 11;151(28):1132-6. doi: 10.1556/OH.2010.28913. Orv Hetil. 2010. PMID: 20570793 Review. Hungarian.
-
Hepatocellular carcinoma: risk factors other than HBV.Ital J Gastroenterol. 1991 Sep-Oct;23(7):457-60. Ital J Gastroenterol. 1991. PMID: 1660333
-
Hepatitis B and C viruses in the development of hepatocellular carcinoma.Crit Rev Oncol Hematol. 1994 Oct;17(2):71-91. doi: 10.1016/1040-8428(94)90020-5. Crit Rev Oncol Hematol. 1994. PMID: 7818788 Review. No abstract available.
-
Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study.J Natl Cancer Inst. 2011 Nov 16;103(22):1686-95. doi: 10.1093/jnci/djr395. Epub 2011 Oct 21. J Natl Cancer Inst. 2011. PMID: 22021666 Free PMC article.
-
Non-viral causes of hepatocellular carcinoma.World J Gastroenterol. 2010 Aug 7;16(29):3603-15. doi: 10.3748/wjg.v16.i29.3603. World J Gastroenterol. 2010. PMID: 20677332 Free PMC article. Review.
Cited by
-
Efficacy and safety of oral branched-chain amino acid supplementation in patients undergoing interventions for hepatocellular carcinoma: a meta-analysis.Nutr J. 2015 Jul 9;14:67. doi: 10.1186/s12937-015-0056-6. Nutr J. 2015. PMID: 26155840 Free PMC article. Review.
-
Association of meat and fat intake with liver disease and hepatocellular carcinoma in the NIH-AARP cohort.J Natl Cancer Inst. 2010 Sep 8;102(17):1354-65. doi: 10.1093/jnci/djq301. Epub 2010 Aug 20. J Natl Cancer Inst. 2010. PMID: 20729477 Free PMC article.
-
Increased systemic zonula occludens 1 associated with inflammation and independent biomarker in patients with hepatocellular carcinoma.BMC Cancer. 2018 May 18;18(1):572. doi: 10.1186/s12885-018-4484-5. BMC Cancer. 2018. PMID: 29776350 Free PMC article.
-
MicroRNA-495 suppresses cell proliferation and invasion of hepatocellular carcinoma by directly targeting insulin-like growth factor receptor-1.Exp Ther Med. 2018 Jan;15(1):1150-1158. doi: 10.3892/etm.2017.5467. Epub 2017 Nov 8. Exp Ther Med. 2018. Retraction in: Exp Ther Med. 2022 Jun 09;24(2):505. doi: 10.3892/etm.2022.11432. PMID: 29434703 Free PMC article. Retracted.
-
Prescription frequency and patterns of Chinese herbal medicine for liver cancer patients in Taiwan: a cross-sectional analysis of the National Health Insurance Research Database.BMC Complement Altern Med. 2017 Feb 20;17(1):118. doi: 10.1186/s12906-017-1628-0. BMC Complement Altern Med. 2017. PMID: 28219357 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical